v3.26.1
Note 17 - Earnings Per Share - Schedule of Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Net (loss) income from continuing operations $ (5,618) $ 3,940 $ (14,237) $ 5,698
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent 0 54 0 558
Net (loss) income $ (5,618) $ 3,994 $ (14,237) $ 6,256
Basic weighted-average common shares outstanding (note 17) (in shares) 10,511,583 6,134,634 9,992,577 6,111,550
Basic - continuing operations (in dollars per share) $ (0.53) $ 0.64 $ (1.42) $ 0.93
Basic - discontinued operations, net of tax (in dollars per share) 0 0.01 0 0.09
Net (loss) income per share (in dollars per share) $ (0.53) $ 0.65 $ (1.42) $ 1.02
Adjusted numerator - net (loss) income from continuing operations (1) [1] $ (5,618) $ 1,679 $ (14,237) $ (2,459)
Net income from discontinued operations, net of tax 0 54 0 558
Net (loss) income $ (5,618) $ 1,733 $ (14,237) $ (1,901)
Diluted weighted-average common shares outstanding (in shares) 10,511,583 8,204,453 9,992,577 8,606,013
Diluted - continuing operations (in dollars per share) $ (0.53) $ 0.2 $ (1.42) $ (0.29)
Diluted - discontinued operations, net of tax (in dollars per share) 0 0.01 0 0.06
Diluted - net (loss) income (in dollars per share) $ (0.53) $ 0.21 $ (1.42) $ (0.22)
Continuing Operations [Member]        
Basic weighted-average common shares outstanding (note 17) (in shares) 10,511,583 6,134,634 9,992,577 6,111,550
Dilutive effect of warrants to purchase common stock (in shares) 0 2,060,510 0 2,482,368
Diluted weighted-average common shares outstanding (in shares) 10,511,583 8,204,453 9,992,577 8,606,013
Continuing Operations [Member] | Restricted Stock and Restricted Stock Units [Member]        
Dilutive effect of Share-Based Payment Arrangements (in shares) 0 9,309 0 12,095
[1] The net (loss) income from continuing operations numerator has been adjusted to remove a gain of $2.3 million and $8.2million for the three and nine months ended March 31, 2025, respectively, due to the changes in fair value of certain warrant liabilities.